Operating Lease, Right-of-Use Asset of NexImmune, Inc. from 31 Dec 2021 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: NexImmune, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Jun 2024.
NexImmune, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2024 was $0, a 100% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NexImmune, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$0	-$703,217	-100%	30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$0	-$836,292	-100%	31 Mar 2024	10-Q	20 May 2024	2024	Q1
Q4 2023	$46,716	-$920,316	-95%	31 Dec 2023	10-Q	07 Aug 2024	2024	Q2
Q3 2023	$536,058	-$559,417	-51%	30 Sep 2023	10-Q	17 Nov 2023	2023	Q3
Q2 2023	$703,217	-$518,451	-42%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$836,292	-$509,389	-38%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$967,032	+$967,032		31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q3 2022	$1,095,475			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$1,221,668			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$1,345,681			31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$0			31 Dec 2021	10-K	28 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.